Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Factors such as the rising prevalence of different forms of cancer, technological advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over conventional surgical procedures, and a rising number of hospitals, surgical centers, and ablation centers are driving the growth of the tumor ablation market globally.
The report titled "Tumor Ablation Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall tumor ablation market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on technology (radiofrequency ablation, microwave ablation, cryoablation, and other technologies), treatment (surgical ablation, laparoscopic ablation, and percutaneous ablation), application (liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications), and different geographical regions.
Geographically, the global tumor ablation market is studied for the following regional markets:
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia-Pacific
China
Japan
Rest of Asia Pacific
Latin America
Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global tumor ablation market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global tumor ablation market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global tumor ablation market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report. Thus, the research study provides a holistic view of the global tumor ablation market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Based on technology, the global tumor ablation market is segmented as follows:
Radiofrequency ablation
Microwave ablation
Cryoablation
Other Technology
Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Special probes are used to burn or freeze tumors without performing conventional surgery. These treatments are also given to patients who are awaiting a liver transplant. Factors such as the rising prevalence of different forms of cancer, the growing number of hospitals, surgical and ablation centers, technological advancements in ablation devices, and the growing adoption of tumor ablation procedures are driving the growth of the tumor ablation market globally. It is observed that in the base year 2016, radiofrequency ablation held the largest market share, and it is anticipated that it will grow at the highest CAGR during the forecast period due to factors such as less risk of tissue damage, a widely accepted method for small tumors, and faster recovery that will influence the growth of the radiofrequency ablation market globally. Radiofrequency ablation is commonly used to treat cancer in the bone, kidney, liver, lung, and prostate.
Based on treatment, the global tumor ablation market is segmented as follows:
Surgical ablation
Laparoscopic ablation
Percutaneous ablation
Ablation refers to the removal of tissue from the body; tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Special probes are used to burn or freeze tumors without the usual surgery. Factors such as the increasing prevalence of different forms of cancer, rising demand for minimally invasive procedures, technological advancements in the field of ablation, and a rising number of hospitals and surgical and ablation centers are driving the growth of the tumor ablation market globally. It is observed that in the base year 2016, surgical ablation held the largest market share due to factors such as the rising prevalence of liver and breast cancer and the increasing use of thoracoscopic surgical ablation, which are fueling the growth of the surgical ablation market worldwide. There are different types of ablations, and various techniques are used to perform the removal of tissue, depending on the nature of the issue. Surgical ablation may be performed with a laser, or radio frequency emissions may be used.
Based on application, the global tumor ablation market is segmented as follows:
Liver cancer
Lung cancer
Kidney cancer
Bone metastasis
Other applications
Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. Special probes are used to burn or freeze tumors without the usual surgery; these treatments are also sometimes performed in patients waiting for a liver transplant. Factors such as the rising prevalence of different forms of cancer, technological advancements in ablation devices, and the growing adoption of tumor ablation procedures are driving the growth of the tumor ablation market globally. It is observed that, in the base year 2016, liver cancer was the largest revenue-generating segment because of the increase in the prevalence of the disease and because tumor ablation is a globally accepted procedure in the treatment of solid tumors in the liver for patients where surgery is not possible or preferred. Tumor ablation is also sometimes performed in patients waiting for a liver transplant. Radiofrequency ablation is used primarily to shrink or slow down the growth of liver carcinoma; it is usually done as an outpatient procedure under light sedation.
For the purpose of this study, the global tumor ablation market is categorized into three segments:
North America
Europe
Asia Pacific
Latin America (LATAM)
Middle East and Africa (MEA)
In the base year 2016, North America dominated the tumor ablation market in terms of revenue, and it is anticipated that it will show significant growth during the forecast period. The U.S. was observed as the largest country-level market in North America. Factors such as the increasing prevalence of different forms of cancer, advanced healthcare infrastructure, higher cost of therapy, technological advances, and increased government funding are the prime contributors to the dominance of North America. It is anticipated that Asia Pacific will grow at the highest CAGR during the forecast period due to developing economic conditions, improved treatment access, an improvement in awareness among the general patient population, rising medical expenditures in emerging economies such as India, China, and Japan, and the growing market penetration of major players in this region, which will drive the market growth in Asia Pacific during the forecast period 2017-2025.
Frequently Asked Questions:
The market for Tumor Ablation Market is expected to reach US$ 1,208.93 Mn By 2025.
The Tumor Ablation Market is expected to see significant CAGR growth over the coming years, at 13.2%.
The report is forecasted from 2015-2025.
The base year of this report is 2014.
Angiodynamics, Inc., Boston Scientific Corp., EDAP TMS S.A., Healthtronics, Inc., Mermaid Medical, Inc. are some of the major players in the global market.
